Navigation Links
Cytonus Therapeutics’ CEO to present at Biotech Showcase in San Francisco
Date:1/12/2020

Cytonus Therapeutics Inc. today announces that Founder and CEO Remo Moomiaie-Qajar, MD has been selected to present at next week’s Biotech Showcase. Cytonus is a leading cell-based platform technology company that has developed a vast platform with its proprietary Cargocyte™ next generation Adoptive Cellular Therapy (ACT) technologies which have numerous medical applications including immunotherapeutic products to treat cancers and inflammatory diseases and to improve patient outcomes. Its innovative platform of products has the potential to improve the health and lives of millions of people across the globe.

Biotech Showcase, held January 13-15 at the Hilton San Francisco Union Square, is one of the Biotech industry’s prime occasions for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of healthcare. Biotech Showcase is an annual industry conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters partnership opportunities. The conference takes place each year during the course of one of the industry's largest gatherings and busiest weeks.

About Cytonus Therapeutics Inc.

Cytonus Therapeutics Inc. is a leading cell-based platform technology company focused on the development of a vast platform of proprietary immunotherapeutic products to cure a wide range of medical conditions including difficult-to-treat cancers and inflammatory diseases, and to improve patient outcomes. Cytonus’ portfolio of inventions addresses the recognized limitations of existing cell-based therapies. Its proprietary Cargocyte™ technologies are Cytonus’ next-generation Adoptive Cellular Therapies (ACT), which have numerous medical applications across multiple therapeutic areas. Cargocytes™ are cellular-engineered enucleated transporters of a multiplicity of therapeutic payloads to tissue in selective, potent, and controllable off-the-shelf cellular therapies that represent an extensive pipeline for treating numerous targeted diseases. Its innovative platform of products has the potential to improve the health and lives of millions of people across the globe. For more information, please visit the Cytonus website at https://cytonus.com and follow its LinkedIn and Twitter feed at: @Cytonus.

About Biotech Showcase

Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present and meet with investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather in San Francisco during this bellwether week which sets the tone for the coming year. Now in its 12th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.

Statements in this news release, which relate to other than strictly historical facts, such as statements about Cytonus’ plans and strategies, new and existing products and technologies, anticipated clinical and regulatory pathways, and markets for its products are forward-looking statements. The words "believe," "expect," "anticipate," "estimate," "project," and similar expressions identify forward-looking statements that speak only as of the date hereof. Such statements involve risks and uncertainties that could cause actual results to differ materially from anticipated results due to many factors, including regulatory and development risks. Cytonus undertakes no obligation to publicly update or revise any forward-looking statements. This news release is neither an offer to sell, nor the solicitation of any offer to purchase, any security.

Follow Cytonus on LinkedIn and Twitter at: @Cytonus, and follow Biotech Showcase at: @EBDGroup and @Demy_Colton.

Read the full story at https://www.prweb.com/releases/cytonus_therapeutics_ceo_to_present_at_biotech_showcase_in_san_francisco/prweb16829330.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Opioid Justice Team: Ad Hoc Committee for babies born opioid-dependent now represented in Purdue bankruptcy proceedings
2. Gym Source Presents Free Optimal Age Fitness & Health Event
3. Guruji Mahendra Trivedi Presents Trivedi Effect® Workshop October 26
4. MindShare Technology CEO Greg Povolny to Present at 2019 Alliance National Conference
5. Ovation Research Accepted for Presentation at ASRM 2019
6. Aspire Regenerative: Dr. McNally and Dr. Inamdar Presenting at the 2019 AIHM Conference
7. Sunovion and The Davis Phinney Foundation Present Innovation Event On Living Well With Parkinson’s
8. Greenberg Traurig Represents CNS Network and Hassman Research Institute in Strategic Merger to Form Apex Innovative Sciences, Inc.
9. Dr. Babak Azizzadeh from the CENTER for Advanced Facial Plastic Surgery is Presenting at the 2019 AAFPRS Annual Meeting
10. Rigaku Presents Latest X-ray Analytical Technology at MS&T19
11. Leveraging Healthcare Technology Guide Now Available To Support Improved Management Of High-Risk Patients And Patient Outcomes Presented By Acuma Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2020)... ... September 01, 2020 , ... Agilent, a ... Agilent Science and Technology Virtual Symposium 2020 (ASTVS 2020) on September ... a suite of Live webinars and Networking sessions, with a vast array of ...
(Date:9/1/2020)... ... September 01, 2020 , ... While coronavirus cases continue to increase ... schools and community organizations remain closed. Because about 80% of blood donations are made ... both blood donors and blood drive hosts to ensure blood products are readily available ...
(Date:8/31/2020)... ... August 31, 2020 , ... Welltech1, the first Israeli ... have invested $400,000 in PopBase, one of two start-ups that beat 152 companies ... Institute (GWI). , The competition was part of the GWI’s The Wellness ...
Breaking Medicine Technology:
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... recently donated 1,400 N95 face masks to medical first responders across the United ... to make donations of personal protective equipment (PPE) medical centers , ...
(Date:8/31/2020)... ... August 31, 2020 , ... Smile Brands Inc., one of ... United States, today announced the grand opening of another affiliated Bright Now! ... enjoy convenient hours, a comfortable office, and full-service care at the new Beaumont ...
(Date:8/31/2020)... ... August 31, 2020 , ... Dr. ... with persons with autism and other developmental disabilities, as well as supporting staff ... education, adolescents with autism, school consultation, and staff development. She joined the company ...
(Date:8/28/2020)... ... 2020 , ... WHAT , Hespiro™ is a new type ... including COVID-19, while reducing the need for scarce mechanical ventilators. It not only ... scrubs it free of carbon dioxide in a completely closed “rebreather” system, important ...
(Date:8/28/2020)... ... 2020 , ... Ziegler, a specialty investment bank, is pleased ... Health, a tech-enabled behavioral health and well-being solutions provider. , Synchronous Health, ... intelligence (AI) to increase access and quality of behavioral health services, and Adventist ...
Breaking Medicine News(10 mins):